Balyasny Asset Management’s Century Therapeutics IPSC Stock Holding History
Bought
Maintained
Sold
Other funds holding IPSC
Balyasny Asset Management's IPSC Position: Q3 2026 in Review
Balyasny Asset Management reduced its Century Therapeutics (IPSC) stake by 0% in Q3 2026, selling an estimated $358 and leaving 5,522,769 shares worth $9.44M. The position accounts for 0.01% of the portfolio, ranked #1110.
Balyasny Asset Management first reported a position in IPSC in Q1 2026 and has held it in 3 quarters since. The position peaked at $13.5M in Q2 2026. 102 funds tracked by Wall St. Rank hold IPSC as of Q3 2026.
- Balyasny Asset Management held 5,522,769 shares of Century Therapeutics worth $9.44M as of Q3 2026.
- Balyasny Asset Management sold 175 Century Therapeutics shares in Q3 2026, an estimated $358.
- Century Therapeutics made up 0.01% of Balyasny Asset Management's portfolio in Q3 2026, its #1110 holding.
- Balyasny Asset Management first reported a position in Century Therapeutics in Q1 2026 and has held it in 3 quarters since.
- Balyasny Asset Management's Century Therapeutics position peaked at $13.5M in Q2 2026.
- 102 funds tracked by Wall St. Rank held Century Therapeutics as of Q3 2026.
Based on Balyasny Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.